Abstract. Hyperlipidemia is a risk factor for Alzheimer's disease (AD) and other neurodegenerative diseases. Proprotein convertase subtilisin/kexin type 9 (PCSK9) is a lipid regulatory gene involved in cell apoptosis. However, the function and mechanism of PCSK9 in neuronal apoptosis following hyperlipidemia remains to be elucidated. The present study established a hyperlipidemic mouse model by feeding a high-fat diet (HFD) to 6-week-old apoE(-/-) mice. Plasma lipid levels, hippocampal lipid accumulation, hippocampal histology, and hippocampal neuronal apoptosis were all monitored for changes. The expression levels of PCSK9, β-secretase 1 (BACE1), B-cell lymphoma 2 (Bcl-2), Bcl-2-associated X protein (Bax), and caspase-3 in hippocampal CA3 and CA1 neurons were also measured. Results demonstrated that a HFD increased the lipid accumulation in the CA3 hippocampus and the levels of plasma lipids, including triglycerides, total cholesterol, low-density lipoprotein, and high-density lipoprotein. In addition, CA3 neurons in the HFD group indicated apparent injuries and increased neuronal apoptosis, which are associated with the expression of Bcl-2, Bax, and caspase-3. A HFD also increased the expression levels of PCSK9 and BACE1. BACE1 promotes cleavage of amyloid precursor proteins to generate β-amyloid peptide (Aβ), which induces neuronal apoptosis. Protein levels of Aβ are associated with the observation of amyloid plaques in the hippocampus of the HFD group. The results suggest that hyperlipidemia regulates neuronal apoptosis by increasing PCSK9 and BACE1 expression. Overall, the current study may elucidate the role of lipid metabolism disorder in AD pathogenesis.
Introduction
Alzheimer's disease (AD) is characterized by a widespread functional disturbance of the human brain. AD pathogenesis is driven by the production and deposition of β-amyloid peptides (Aβs) (1) . Aβs are peptides composed of 36-43 amino acids, which are the predominant components of the amyloid plaques observed in the brains of AD patients. Aβ is formed from the cleavage of amyloid precursor protein (APPs) by β-and γ-secretases. The formation of amyloid plaques is a major factor in AD, thus, determining the underlying mechanism by which Aβ induces neuronal cell death is crucial. A recent study demonstrated that dying cells in AD brains and cultures of neurons exposed to Aβ exhibit the characteristics of apoptosis (2) . However, the specific signaling pathways by which Aβ triggers cell apoptosis have not been well defined.
Hyperlipidemia is a risk factor for atherosclerosis, as well as for neurodegenerative diseases, including AD, as evidenced by epidemiological, clinical, and animal studies. Kivipelto et al (3) and Solomon et al (4) selected 1449 residents for a 21-year follow-up study and demonstrated that total cholesterol was an independent risk factor for AD in middle-aged adults. Lipid-lowering treatment can reduce the risk of neurodegenerative diseases (5-7). Chan et al (8) observed that sphingomyelin and cholesterol esters were notably increased in AD patients and transgenic AD mouse brain tissues. Kosari et al (9) demonstrated that hippocampus-dependent memory was markedly impaired in rats fed with a HFD for 12 weeks. Furthermore, El-Sayyad et al (10) observed a higher rate of neuronal apoptosis in rats with hyperlipidemia compared with those fed a normal diet.
Despite years of intensive research, the link between hyperlipidemia and AD has yet to be established, although it has previously been suggested that genes regulating lipid metabolism may also be important in AD (11 termed neuronal apoptosis-regulated convertase-1, a proprotein convertase belonging to the subtilase subfamily (12) . PCSK9 is highly expressed in the liver, where it negatively regulates the low-density lipoprotein (LDL) receptor (LDLR) in hepatocytes and, thus, is important in controlling circulating levels of LDL-cholesterol (LDL-C) (13) . PCSK9 affects neural development and participates in neuronal apoptosis (12) . Our previous study reported that high PCSK9 expression levels, induced by oxidized LDL (oxLDL), were positively associated with a high apoptotic ratio in human umbilical vein endothelial cells (14) . The present study investigated whether PCSK9 was involved in the effects of hyperlipidemia on hippocampal neuronal apoptosis by establishing an apoE(-/-) hyperlipidemic mouse model. Furthermore, the current study aimed to investigate a novel association between lipid metabolism and AD.
Materials and methods

Animals and diets.
A total of 18 male apoE(-/-) mice (age, 6 weeks; average weight, 21±2.7 g), were purchased from Nanjing Qingzilan Technology Co., Ltd. (Nanjing, China) and maintained in a temperature-controlled environment (22-25˚C, 45% humidity) with a 12 h light-dark cycle. Mice were randomly assigned to one of two groups: HFD group, fed with food consisting of 2% (w/w) cholesterol, 10% (w/w) lard, and 0.5% (w/w) cholic acid; and a normal diet (ND) group. All mice were allowed ad libitum access to their designated diet for 12 weeks. All animal procedures were conducted in accordance with the International Guidelines for the Ethical Use of Laboratory Animals and the National Institutes of Health Guide for the Care and Use of Laboratory Animals (15) .
Plasma lipid analysis. At the end of the feeding period, animals were anesthetized with 10% chloral hydrate (350 mg/kg body weight). Blood was collected using cardiac puncture into tubes containing 0.1% EDTA following an overnight fast. Blood was then centrifuged at 5,500 x g for 12 min at 4˚C to separate the plasma. The plasma was immediately used to determine the levels of LDL-C, high-density lipoprotein cholesterol (HDL-C), total cholesterol (TC), and triglyceride (TG) using an automatic biochemistry analyzer (AU480 Chemistry system; Beckman Coulter, Inc., Brea, CA, USA).
Tissue preparation for morphological analyses. Following reaching surgical tolerance, the anesthetized animals were sacrificed by cervical dislocation, and were transcardially perfused with physiological saline for 60 sec, followed by perfusion with a fixative (4% w/v formaldehyde) for 15 min at 22˚C. Following perfusion, the brains were rapidly dissected without the olfactory bulb and cerebellum. The brains were post-fixed overnight (18-22 h) Bcl-2-associated X protein (Bax; 1:50; cat. no. 60267-1-Ig; Proteintech Group, Inc.). Incubation without the primary antibodies served as the negative control. The frozen 8-µm thick sections were blocked with endogenous peroxidase blocking agent (Fuzhou Maixin Biotech, Co., Ltd., Fuzhou, China) for 10 min at room temperature and subsequently incubated with the different primary antibodies for 30 min at room temperature. Following washing in distilled water, the sections were incubated with biotinylated secondary antibodies (cat. nos. KIT-0105R and KIT-0105M; Fuzhou Maixin Biotech, Co., Ltd.) and streptavidin-peroxidase (Proteintech Group, Inc.) for 10 min at room temperature. Subsequently, 3,3'-diaminobenzidine peroxidase substrate solution (Fuzhou Maixin Biotech, Co., Ltd.) was added until the desired color (brown) was developed. Apoptotic cells in the mouse hippocampus were detected using a Hoechst 33258 Staining kit (Beyotime Institute of Biotechnology, Haimen, China) in accordance with the manufacturer's protocols.
Modified Bielschowsky staining for substance P (SP).
Frozen slides were immersed in 2% silver nitrate solution for 30 min at 37˚C in the dark. Subsequently, the silver nitrate solution was removed and the slides were washed three times in distilled water for 3 min. The stain was deoxidized with 10% reducing agent until the color of the slides turned pale yellow. The slides were rinsed again three times in distilled water, and excess water was removed. Ammoniacal silver solution was added to each slide for 30 sec. The excess solution was removed, and the slides were immersed in 10% reducing agent for 2 min. The slides were rotated a number of times until the yellow dye was stabilized. The slides were then rinsed in tap water, fixed in 5% sodium thiosulfate for 3 min, air-dried, cleared in xylene, and finally coverslipped for light microscopic examinations.
Statistical analysis. Experimental results were expressed as the mean ± standard error of the mean. Statistical analyses were conducted using unpaired Student's t-test assuming unequal variance unless otherwise indicated. Statistical analyses were conducted using SPSS 13.0 (SPSS, Inc., Chicago, IL, USA). P<0.05 was considered to indicate a statistically significant difference.
Results
Comparison of plasma lipid profiles between ND and HFD mice.
The apoE(-/-) mouse has been established as a suitable model to investigate diet-induced hyperlipidemia. ApoE(-/-) mice (age, 6 weeks) were randomly assigned to receive either ND or HFD for 12 weeks. The plasma lipid profiles, including TC, TG, LDL-C, and HDL-C contents, were determined for the two groups of mice. The data for plasma lipid levels are presented in Table I . Plasma TG, TC, LDL-C, and HDL-C concentrations were significantly increased in HFD-fed mice compared with ND-fed mice. These results indicated that a diet-induced hyperlipidemic model was successfully established.
Effects of HFD on lipid accumulation in the hippocampus of ApoE(-/-) mice.
Lipids are essential to brain functions, including membrane morphology, signal transduction, membrane fluidity, and cell survival. Lipid abnormalities in the brain may contribute to AD risk or severity. However, the mechanism by which hyperlipidemia affects lipid accumulation in the hippocampus, which is a central target of AD plaque pathology, remains to be elucidated. In the present study, hippocampal sections were Figure 2 . Hyperlipidemia results in structural damage and neuronal loss in the hippocampus of HFD-fed apoE(-/-) mice. Hematoxylin and eosin stained hippocampus CA1 and CA3 neurons from apoE(-/-) mice fed with ND or HFD for 12 weeks. CA1 (magnification, x400) indicated by the white rectangular frame (magnfication, x40) and CA3 (magnification, x400) indicated by the black rectangular frame (magnification, x40). ND, normal diet; HFD, high-fat diet. Figure 3 . Hyperlipidemia increases neuronal apoptosis in hippocampal CA3 neurons. Hoechst 33258-stained hippocampus CA1 and CA3 from apoE(-/-) mice fed with ND or HFD for 12 weeks (magnification, x400). Cells with nuclei exhibited marked chromatin condensation and nuclear fragmentation (indicated by the red arrows) were considered to be apoptotic. ND, normal diet; HFD, high-fat diet.
stained with Oil Red O to identify the sites of lipid accumulation in apoE(-/-) mice fed with ND and HFD. The majority of the Oil Red O-stained particles were distributed as clusters in the hippocampus tissues. Lipid accumulation increased in hippocampus CA3 neurons in HFD-fed apoE(-/-) mice compared with ND-fed apoE(-/-) mice. However, the difference in lipid contents between ND-and HFD-fed mice was not notable in hippocampus CA1 of apoE(-/-) mice (Fig. 1) . The results indicated that the lipid contents of the hippocampus can be increased by HFD-induced hyperlipidemia.
Effects of HFD on histology of the hippocampus in apoE(-/-)
mice. The histological changes in the hippocampus were observed in the two groups of mice following H&E staining of the brain sections. ND-fed apoE(-/-) mice exhibited normal histological appearance and neuronal distribution in CA1 and CA3 hippocampal areas. Degenerative changes were observed in CA3 hippocampal areas of HFD-fed apoE(-/-) mice, which exhibited pyknotic cells with reduced neuron count. Enlarged intercellular spaces between CA1 and CA3 pyramidal cells were frequently observed in HFD-fed apoE(-/-) mice. Furthermore, a number of cells in the CA3 area of HFD-fed apoE(-/-) mice lost typical cell structure compared with ND-fed mice (Fig. 2) . These results suggested that hyperlipidemia may result in structural damage and neuronal loss in the hippocampus of HFD-fed apoE(-/-) mice.
Effects of HFD on neuronal apoptosis in the hippocampus of apoE(-/-) mice.
Marked neuronal loss in the hippocampus is often observed in AD brains. To observe whether neuronal apoptosis may be induced by hyperlipidemia, a Hoechst 33258 staining assay was performed to detect cell apoptosis in the hippocampus. Neuronal apoptosis was observed in a number of cells in the hippocampus CA3 of ND-fed apoE(-/-) mice. By contrast, a large number of hippocampus CA3 neuronal cells underwent apoptosis in HFD-fed apoE(-/-) mice. Although individual apoptotic cells were observed in hippocampus CA1 of HFD-fed apoE(-/-) mice, no notable difference was observed between the percentage of apoptotic cells in hippocampus CA1 between ND-and HFD-fed mice (Fig. 3) . These results demonstrated that apoptosis was the predominant cause of neuronal death in the hippocampus, and hyperlipidemia increases neuronal apoptosis in hippocampus CA3 of apoE(-/-) mice.
Effects of HFD on Bcl-2, Bax, and caspase-3 expression levels in the hippocampus of apoE(-/-) mice.
To investigate the underlying molecular mechanisms of hyperlipidemia-induced apoptosis of hippocampal neurons, apoptosis-associated protein expression in the hippocampus of apoE(-/-) mice was observed via immunohistochemistry. The expression of caspase-3, which is the major executioner caspase during the demolition phase of apoptosis, was markedly higher in CA3 of HFD-fed mice than in ND-fed mice, and pro-apoptotic protein Bax also increased in CA1 and CA3 of HFD-fed apoE(-/-) mice. Notably, anti-apoptotic protein Bcl-2 slightly increased in CA3 of HFD-fed apoE(-/-) mice (Fig. 4) . These results indicated that hyperlipidemia-induced hippocampal neuronal apoptosis of apoE(-/-) mice may be controlled via the Bcl-2/Bax-caspase-3 signaling pathway.
Effects of HFD on PCSK9 and BACE1 expression in the hippocampus of ApoE(-/-) mice.
PCSK9, an apoptosis-associated protein, may degrade BACE1, the predominant enzyme cleaving APP to generate Aβ. Aβ is another key apoptosis inducer in neurodegenerative diseases. To determine whether PCSK9 and BACE1 are involved in hippocampal neuronal apoptosis, changes in PCSK9 and BACE1 expression levels in the hippocampus of apoE(-/-) mice were observed by immunohistochemistry. PCSK9 expression in CA1 and CA3 of HFD-fed apoE(-/-) mice notably increased compared with ND-fed apoE(-/-) mice. Furthermore, BACE1 expression in CA3 of HFD-fed apoE(-/-) mice notably increased (Fig. 5) . These results suggested that PCSK9 and BACE1 may be associated with hyperlipidemia-induced hippocampal neuronal apoptosis.
Effects of HFD on amyloid plaques in the hippocampus of apoE(-/-) mice.
To further elucidate the role of BACE1 in hyperlipidemia-induced hippocampal neuronal apoptosis, the changes in levels of SP in the brains in ND-and HFD-fed apoE(-/-) mice were compared using modified Bielschowsky staining, which allowed visualization of diffuse plaques in the brains. Small amyloid plaques were observed in the hippocampus of HFD-fed apoE(-/-) mice but not in ND-fed apoE(-/-) mice (Fig. 6 ). This finding was consistent with the expression pattern of BACE1.
Discussion
Neurodegenerative diseases, which affect tens of millions of people annually worldwide, are characterized by the physical decay and eventual loss of neurons. AD is one of the most common neurodegenerative diseases, which predominantly affects the bilateral frontotemporal lobe and hippocampus. Histopathology indicates deposition of senile plaques, neurofibrillary tangles, lost neurons, and glial hyperplasia. Neuronal apoptosis is one of the major pathological characteristics of AD. The majority of cases of AD have a genetic element, although sporadic cases of this disease have been reported. To date, no specific treatment is able to reverse the progression of AD. Limiting this harmful disease is one of the most critical challenges in current medicine.
Hyperlipidemia is a risk factor of AD and other neurodegenerative diseases, as evidenced by epidemiological (3,4) , clinical, and experimental studies (8) (9) (10) . In the present study, 18 six-week-old apoE(-/-) mice were randomly divided into two groups: ND and HFD. After 12 weeks of feeding, hippocampal tissues were collected for frozen sectioning. Compared with the ND group, pyramidal cells in the hippocampus of apoE(-/-) mice fed with HFD were disordered. In addition, intercellular spaces increased, cells swelled, and nuclei became smaller and hyperchromatic, exhibiting karyopyknosis, particularly in CA3 areas. By contrast, CA1 indicated no notable changes. These results suggested that hyperlipidemia results in structural damage in the hippocampus of HFD-fed apoE(-/-) mice. Oil red O staining demonstrated that HFD-fed apoE(-/-) mice exhibited slightly increased lipid accumulation levels compared with ND-fed apoE(-/-) mice in hippocampus CA3. This staining also demonstrated that plasma lipids can pass through the blood-brain barrier (BBB) into the brain tissues when hyperlipidemia occurs, resulting in increased lipid deposits in the pyramidal cells of the hippocampus. Stranahan et al (16) also observed that free cholesterol levels in the hippocampus were markedly increased following induction of hyperlipidemia in Sprague-Dawley (SD) rats by feeding with high-fat and high-sugar diets for 3 months. Generally, blood lipids cannot completely pass through BBB, however, previous studies have indicated that the permeability of BBB in apoE(-/-) mice is 3.7 times of ordinary mice (17, 18) . This increase in permeability results in the passage of nonessential small molecules into the brain, leading to brain function disorders. This may be attributed to HFD-induced AD of apoE(-/-) mice (17) . The increased raw material for lipid synthesis in the blood passes through the BBB freely, possibly increasing the lipid contents in the brain. Furthermore, lysophosphatidic acid, the predominant bioactive lipid of oxLDL, may damage BBB, leading to the occurrence of AD (19) .
Although hyperlipidemia has been identified as a risk factor of AD, the mechanism of hyperlipidemia-induced AD has not been completely elucidated. It has been demonstrated that following feeding C57BL/6 and LDLR-/-mice with a HFD for 8 weeks, the expression levels of a number of cytokines, including tumor necrosis factor-α, interleukin-1, interleukin-6, nitric oxide synthase-2, and cyclooxygenase-2, increased along with BACE1 expression, suggesting that hypercholesterolemia results in nerve inflammation and influences the APP metabolic pathway, resulting in neurodegenerative diseases (20) . Stranahan et al (16) observed that the levels of lipid peroxidation products 4-hydroxynonenal-lysine and 4-hydroxynonenal-histidine were locally increased in the hippocampus subsequent to feeding SD rats high-fat and high-sugar diets for 3 months to induce hyperlipidemia, indicating cell membrane-associated oxidative stress. On the basis of the above results, the present study suggests that hyperlipidemia can increase lipid deposition and promote cell apoptosis, leading to neuronal degeneration.
Hoechst 33258 staining results indicated that pyramidal cells in hippocampus CA3 of HFD-fed apoE(-/-) mice exhibited greater apoptosis than ND-fed apoE(-/-) mice, indicating that hyperlipidemia increased neuronal apoptosis in the hippocampus. Furthermore, the expression of PCSK9, BACE1, caspase-3, and Bax significantly increased, whereas Bcl-2 expression increased only marginally, indicating that hyperlipidemia resulted in neuronal apoptosis in the hippocampus of apoE(-/-) mice possibly via the Bcl-2/Bax-caspase-3 signaling pathway.
PCSK9 is a newly identified gene associated with blood cholesterol metabolism. Its predominant biological function is the degradation of LDLR in hepatic cells. PCSK9 function has been comprehensively investigated, revealing its regulatory functions, such as regulation of neuronal apoptosis in addition to lipid metabolism (21) . A previous study demonstrated that when cerebellar granule neurons were damaged, PCSK9 expression increased, activating the caspase-3 and caspase-9 signaling pathways, possibly leading to apoptosis (21) . The current study observed that PCSK9 expression in hippocampal CA3 of HFD-fed apoE(-/-) mice was significantly increased compared with that in the ND-fed group. Combined with previous experimental findings, the results of the present study suggest that PCSK9 is important in neuronal apoptosis of HFD-fed apoE(-/-) mice.
Numerous studies have confirmed that the large number of Aβ deposits in the brain is an important risk factor for the occurrence of AD (22, 23) . As previously mentioned, BACE1 is the predominant enzyme producing Aβ from APP. Aβ-induced neuronal apoptosis leads to AD. BACE1 protein expression levels and enzyme activities increased in the majority of sporadic AD patients. The present study also compared the changes of substance P levels in the brains of ND-and HFD-fed apoE(-/-) mice using modified Bielschowsky staining, and a slightly increased SP deposition was observed in the hippocampus of HFD-fed apoE(-/-) mice. This is consistent with previous studies that have observed that HFD can lead to an increase in SP deposition (24) (25) (26) . Although numerous studies have verified the association between lipids and Aβ, the underlying mechanism remains to be elucidated.
PCSK9 expression was demonstrated to be negatively associated with BACE1 level in certain studies (27, 28) , however, other reports have indicated no association between PCSK9 and BACE1 (29) . Thus, the correlation between PCSK9 and BACE1 requires further elucidation. The present study investigated the association between PCSK9 and BACE1 and observed that PCSK9 and BACE1 expression increased in HFD-fed apoE(-/-) mice. Furthermore, BACE1 mRNA and protein levels increased subsequent to feeding C57BL/6 and LDLR-/-mice a HFD for 8 weeks (20) . Thus, the association between PCSK9 and BACE1 requires further investigation at a cellular level.
In conclusion, the present study demonstrated that hyperlipidemia can induce apoptosis of hippocampal neurons in apoE(-/-) mice, and that PCSK9 may be involved in this process.
